KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanomaGlobeNewsWire • 04/19/26
Immunocore to present at the 25th Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/06/26
Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meetingGlobeNewsWire • 03/17/26
Immunocore reports fourth quarter and full year 2025 financial results and provides a business updateGlobeNewsWire • 02/25/26
Immunocore to report fourth quarter and full year 2025 financial results and host call on February 25, 2025GlobeNewsWire • 02/18/26
Immunocore (IMCR) Soars 5.9%: Is Further Upside Left in the Stock?Zacks Investment Research • 01/22/26
Immunocore Holdings plc (IMCR) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/09/26
Immunocore (IMCR) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 01/08/26
Immunocore: Continuing To Improve The Bottom Line, But Needing A Big CatalystSeeking Alpha • 11/08/25
Immunocore presents Phase 1 data for hepatitis B candidate at AASLD's The Liver MeetingGlobeNewsWire • 11/07/25
Immunocore (IMCR) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research • 11/06/25
Immunocore reports third quarter financial results and provides a business updateGlobeNewsWire • 11/06/25
Immunocore Holdings Plc (IMCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/10/25
Compared to Estimates, Immunocore (IMCR) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/07/25
Immunocore to report second quarter 2025 financial results and host call on August 7, 2025GlobeNewsWire • 07/31/25
Wall Street Analysts See a 72.34% Upside in Immunocore (IMCR): Can the Stock Really Move This High?Zacks Investment Research • 07/24/25
Er-Kim Announces Exclusive Agreement with Immunocore to Distribute KIMMTRAK in Turkey, and the MENA, Caucasus and CIS RegionsGlobeNewsWire • 06/30/25